Genesem Q1 2026 Swings to Operating Loss, Debt Ratio Rises, Plans Treasury Share Cancellation
Consolidated Q1 2026 revenue: 6.73 billion won (down 20% from 8.43 billion won in Q1 2025), operating loss of 2.47 billion won (vs operating profit of 1.03 billion won in Q1 2025), net loss of 1.68 billion won (vs net loss of 1.26 billion won in Q1 2025, widening loss)
Debt ratio: 81.85% (up from 70.32% at year-end 2025); cash and cash equivalents: 8.42 billion won (down from 16.02 billion won)
Order backlog: 42.46 billion won; R&D expenses: 1.34 billion won (19.93% of revenue)
FY2025 dividend: 50 won per share paid
Plan to cancel treasury shares (according to Commercial Act Article 341-4)
In January 2026, signed a 4.8 billion won contract for semiconductor automation equipment (delivery in progress)